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ABSTRACT
Manganese (Mn) is a required co-factor for many ubiquitous enzymes; however,
chronic manganese overexposure can cause manganism, a parkinsonian-like
syndrome. Previous studies showed manganese influx into brain is carrier-mediated,
though the putative carrier(s) were not established. Studies conducted with cultured
bovine brain microvascular endothelial cells (bBMECs), which comprise the bloodbrain barrier, revealed 54Mn (II) uptake positively correlated with pH, was
temperature-dependent, and was sodium- and energy-independent. Brain 54Mn
uptake correlated inversely with calcium (Ca) concentration, but 45Ca uptake was
unaltered by high Mn concentration. Lanthanum (La), a non-selective inhibitor of
several Ca channel types, as well as verapamil and amiloride, inhibitors of voltageoperated Ca channels, failed to inhibit Mn uptake into cells. Nickel (Ni), another nonselective inhibitor of several Ca channel types, inhibited Mn and Ca uptake into cells
by 88 and 85 %, respectively. Cyclopiazonic acid (CPA) and thapsigargin, which
activate store-operated calcium channels (SOCCs), increased 54Mn and 45Ca uptake
into cultured bBMECs. In situ brain perfusion studies were conducted in adult, male
Sprague-Dawley rats to verify the cell culture results. Both nickel and verapamil
produced a non-significant decrease in Mn and Ca influx. Lanthanum significantly
increased Mn influx to 675 and 450 % of control in parietal cortex and caudate,
respectively, while producing no significant effect on Ca influx. Vanadate, which
inhibits Ca-ATPase, inhibited Mne uptake into cultured blood-brain barrier cells, but
not into perfused rat brain. Overall these results suggest that both Ca-dependent
and Ca-independent mechanisms play a role in brain Mn influx. This work provides
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evidence that store-operated Ca channels, as well as another blood-brain barrier
transporter, are likely to mediate carrier-mediated Mn influx into the brain.

Running title: Mn brain influx at the BBB through SOCs

Key words/phrases: manganese, blood-brain barrier, influx, store-operated calcium
channel
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INTRODUCTION
The trace element manganese (Mn) is essential for normal brain development and
function throughout the life span of all mammals (Keen et al., 2000). Mn is a cofactor for many enzymes, including the brain-specific enzyme glutamine synthetase
(Wedler and Denman, 1984) and ubiquitously expressed enzymes including
superoxide dismutase 2 and pyruvate carboxylase (Keen, et al., 2000). While Mn is
essential for normal brain function, excess brain Mn is neurotoxic and can produce
manganism, a parkinsonian-like syndrome (Hudnell, 1999; Iregren, 1999).
Neurotoxicity due to excess Mn has been reported following occupational inhalation
exposure to Mn in mining operations (Couper, 1837), in dry-cell battery production
(Keen and Lönnerdal, 1995), in ferromanganese smelting (Huang et al., 1989) and
during Mn welding operations (Chandra et al., 1981; Ono et al., 2002); following nonoccupational exposure to inhaled Mn (Hudnell, 1999) and following intestinal
exposure of Mn in drinking water. There is currently significant concern about airborne
Mn exposure from the fuel additive methylcyclopentadienyl manganese tricarbonyl
(MMT) (Hudnell, 1999). Current treatments for patients with manganism may
postpone the progression of symptoms, but have not been able to cure the disease
(reviewed in (Lee, 2000).

As the general public’s Mn exposure increases with increased MMT use, the
mechanisms of Mn homeostasis become more important in understanding and
assessing the risk of neurotoxicity. Mn brain entry from blood can occur through the
capillary endothelial cells of the blood-brain barrier (BBB) and through the choroid
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plexuses. Several studies suggested that Mn ion brain influx at the BBB is carriermediated (Aschner and Aschner, 1990; Murphy et al., 1991; Rabin et al., 1993;
Aschner and Gannon, 1994; Crossgrove et al., 2003). Similarly, Mn appears to be
actively transported into bile, achieving a concentration gradient as high as 100-fold
(Klaassen, 1974). The identity of the Mn carrier(s) is unknown. Mn efflux across the
BBB does not appear to occur through a carrier but rather by diffusion (Yokel et al.,
2003). Several studies suggested that the divalent metal transporter-1 (DMT-1) may
be responsible for Mn ion influx into brain (Goddard et al., 1997; Gunshin et al.,
1997; Conrad et al., 2000), but a recent report suggests that the lack of functional
DMT-1 in rats has no effect on brain influx of the Mn ion or the Mn-transferrin
complex (Crossgrove and Yokel, 2004).

The current work examined whether brain Mn influx at the BBB is mediated by one
or more calcium (Ca) transport pathways. Ca inhibited Mn entry into Hep-G2 cells
(Finley, 1998). Cell Mn entry across cell membranes was decreased by Ca inhibitors
(Mason et al., 1993) and increased by activators of Ca influx (Kerper and Hinkle,
1997a). Mn entry through store-operated Ca channels (SOCs) has been
demonstrated in rat mast and osteoblast-like cells and human platelets (Fasolato et
al., 1993; Dobrydneva and Blackmore, 2001; Baldi et al., 2002). Others have
reported evidence of SOCs on brain endothelial cells (Kerper and Hinkle, 1997b;
Kim et al., 2004). In this work, we examined the mechanism(s) of Mn brain entry
across the BBB. We first examined general characteristics of Mn uptake at the BBB
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and then tested the hypothesis that Mn influx at the BBB occurs through one or more
Ca influx processes.

MATERIALS AND METHODS
Materials
54MnCl
2

(specific activity 107 or 38 nCi/ng; total Mn 184 or 477 nM) in 0.5 M HCl was

purchased from Perkin-Elmer/NEN (Boston, MA). 45CaCl2 (5.87 nCi/ng) in water was
purchased from Perkin-Elmer/NEN. [14C]sucrose was purchased dry from PerkinElmer/NEN (3.6 nCi/nmol) and in 2% ethanol from Moravek (Brea, CA; 495
nCi/nmol) or American Radiolabeled Chemicals, Inc. (620 nCi/nmol). All other
chemicals were purchased from Sigma (St. Louis, MO) unless otherwise noted.
Sprague-Dawley rats (225-300 g) were purchased from Harlan (Indianapolis, IN).
Verapamil was solubilized in methanol, diluted and delivered in 0.2% methanol.
Thapsigargin was solubilized by DMSO and cyclopiazonic acid by methanol and
delivered in 0.1% DMSO or methanol. Vehicle controls contained equimolar solvent.
All animal research was conducted under the guidelines of the Guide for the Care
and Use of Laboratory Animals and with the approval of the University of Kentucky
Institutional Animal Care and Use Committee.

Isolation of bovine brain microvascular endothelial cells (bBMECs)
The bBMECs were isolated from fresh bovine brains, as described (Bowman et al.,
1983; Audus et al., 1996). Cells were grown in 35 mm plastic dishes at 37°C in 5%
CO2 with nutrient media containing 10% horse serum in 50% MEM and 50% Ham’s
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F-12 supplemented with NaHCO3 (13 mM), HEPES (10 mM) penicillin G (100 U/mL)
and streptomycin (100 µg/ml). Cell identity was verified by the presence of the
following characteristics of bBMECs. 1.) They were positive for γglutamyltransferase and alkaline phosphatase activity. 2.) They did not have the
processes or shapes of neurons or glial cells according to morphologic analysis of
TEM images. 3.) They took up histidine (Yamakami et al., 1998).

Studies of 54Mn uptake conducted in bBMECs
54Mn

uptake was determined in 85-90% confluent cell cultures following procedures

established for another BBB cell line (Yokel et al., 2002). In summary, each cellcontaining culture dish was rinsed three times with a wash solution containing (in
mM): Na+ 122, K+ 4.2, Ca2+ 1.5, Mg2+ 0.9, Cl- 131, HEPES 10, and D-glucose 10 at
pH 7.4 and at the temperature of the uptake experiment. The last wash remained in
the dish at least 10 minutes to bring the cells to the temperature of the uptake
experiment. The cells were incubated with 0.75 mL uptake solution consisting of
wash solution containing 54Mn2+ (~1 µCi/mL) and [14C]-sucrose (1 µCi/mL; 0.2 µM) in
the presence or absence of treatment. After 10 to 120 minutes the uptake solution
was removed and the cells rapidly washed 5 times with ice-cold wash solution. Cells
were solubilized in 1 M sodium hydroxide for 15 min at room temperature then
neutralized with equimolar HCl. Aliquots of cell lysates were collected for analysis of
radioactivity and total protein content.
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Cell viability was measured in parallel dishes of cultured bBMECs exposed to the
same treatments in the absence of the radionuclides. Cell membrane integrity was
measured by determining the activity of the cytosolic enzyme lactate dehydrogenase
(LDH) released into the uptake media. LDH activity was measured with an assay kit
(Sigma). Cell redox potential, an indicator of cell health, was measured by
methylthiazoletetrazolium (MTT) conversion to its formazan product. When MTT
conversion was less than 80% of control the cells were considered to have
drastically changed. Data from these cells were not used (except in studies of
metabolic inhibitors and low temperature).

bBMECs were selected as a model of the BBB to screen characteristics of Mn uptake,
with the intent of following significant findings in the intact rat. Initially, Mn uptake into
bBMECs was measured from 10-120 minutes at pH 6.4 and 7.4 to determine
whether it was linear, as several pHs were used in subsequent studies. 54Mn2+
uptake over 30 minutes was measured in media buffered to pH 5.4, 6.4, 6.9, 7.4 and
7.9 by 10 mM potassium hydrogen phthalate (pH 5.4), PIPES (pH 6.4), MOPS (pH
6.9), or HEPES (pH 7.4 and 7.9). Mn uptake was also measured during a 30 minute
incubation at 4 (on ice), 8, 21, 30 and 37°C; at 37°C in the presence of a metabolic
inhibitor, 2,4-dinitrophenol (0.25 mM) or azide (10 mM); and with the replacement of
glucose (10 mM) by 2-deoxyglucose (10 mM). The role of sodium in Mn uptake was
measured by replacing 50 or 100% of the sodium in the uptake media with choline or
lithium or by the addition of ouabain (0.1 mM). The role of Ca transporters in Mn
uptake was examined by changing Ca concentration from 0 to 1.5 mM; by addition
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of Ca transporter inhibitors including vanadate (0, 0.003, or 1 mM), lanthanum (La3+;
0.050 mM as La(NO3)3), nickel (Ni; 1 mM as NiCl2) or verapamil (0.3 mM); or by
addition of the Ca transporter activators cyclopiazonic acid (CPA; 0.01 mM) and
thapsigargin (0.001 mM).

In situ brain perfusion studies
Rats were prepared and perfused as described previously (Crossgrove, et al., 2003).
Briefly, a cannula containing heparinized saline was inserted into the right common
carotid artery. The open end was transferred to a syringe containing a perfusate with
the treatment and/or radioisotope tracers. Perfusate delivery was regulated by a
syringe pump. Immediately before brain perfusion began, the rat’s cardiac ventricles
were severed to avoid mixing of blood with perfusate. The perfusion (45, 90 or 180
s) was terminated by decapitation. The brain was extracted and the ipsilateral
parietal cortex, caudate and lateral ventricular choroid plexus removed, weighed and
assayed for radioactivity. In some experiments, the cerebrum was homogenized
according to the capillary depletion method as described (Crossgrove, et al., 2003).

The perfusate contained 1 to 2 µCi 54Mn2+/ml and a marker for vascular and
extracellular space, 14C-sucrose (1 µCi/ml), in a solution containing (in mM): Na+
122, K+ 4.2, Ca2+ 1.5, Mg2+ 0.9, Cl- 131, glucose 10, and HEPES 10. To test the
hypothesis that Mn and Ca share one or more transporters, rats were treated with
perfusates containing 54Mn2+ and 0 added, 1.5 (control) or 9 mM Ca or 45Ca and Mn
(0 or 15 mM). Other experiments included the Ca transporter inhibitors sodium
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vanadate (1 or 10 mM), p-hydroxyhippuric acid (0.4 mM), verapamil (0.3 mM) or
amiloride (0.84 mM) to determine whether Ca transporters play a role in rat brain Mn
influx.

Radioactivity and total protein determination
Radioactivity of 54Mn and 14C were determined in aliquots of cell lysate or in digested
tissue as described (Crossgrove, et al., 2003). Radioactivity from 45Ca was counted
from 156-257 keV by a liquid scintillation counter, with appropriate corrections for
crossover, quench and decreased efficiency due to the narrowed counting window.
Protein concentration in cell lysates was measured via the bicinchoninic acid method
with a kit (Sigma).

Data and statistical analysis
In bBMEC experiments, 54Mn, 45Ca and 14C activities (dpm/dish) and total protein
(mg/dish) were calculated. 54Mn, 45Ca and [14C]-sucrose uptake values were
converted to dpm/mg protein. Non-specific binding to cell and collagen surfaces was
determined by apparent uptake in 15 s on ice. Collagen was found to sequester Mn,
but not 14C or 45Ca, during the time course of these experiments. Estimated
confluence was used to predict the surface area of the collagen-coated dish that was
exposed to 54Mn uptake media. Uptake into collagen was determined as:

Mn uptake into collagen = (100%-confluence%)*(uptake into collagen-only dish)
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Nonspecific Mn adsorption to the dish was also determined several times. It was
negligible. Non-specific binding and estimated binding to collagen were subtracted
from total uptake to obtain corrected values for 54Mn, 45Ca, and 14C uptake into cells.
These corrected values (dpm/mg protein) were divided by the activity of the uptake
solution (dpm/ml) to obtain a volume of distribution of uptake (ml/mg protein) from
uptake media.

The [14C]-sucrose volume represents diffusional and pinocytotic uptake processes.
This value was subtracted from the 54Mn and 45Ca volumes of distribution to
generate a term expressing Mn or Ca uptake into the cells via carrier(s). Mn uptake
(ml/mg protein) was converted to pmol Mn/mg protein by multiplying by total Mn
concentration. Intracellular Mn concentration was then estimated from the
relationship of 2 µl intracellular space per mg total protein (Edlund and Halestrap,
1988; Poole et al., 1989).

In perfusion experiments, radioactivity (dpm/g tissue) was divided by perfusate
activity (dpm/ml) to calculate the volume of distribution (ml/g). This was divided by
the perfusion duration (45 to 90 s) to obtain the influx transfer coefficient (Kin), as
described in detail (Crossgrove, et al., 2003). All bBMEC experiments were
completed with at least three replicates per experiment, each conducted in duplicate
or triplicate. Results of the time course of Mn uptake at pH 6.4 and 7.4 were
analyzed by regression analysis using GraphPad Prism to determine if uptake was
best fit by a first or second order relationship. Uptake in the presence of treatments
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was converted to a percent of control uptake for each experiment. The mean and
relative standard deviation were calculated. For cell and perfusion experiments, ttests or one-way ANOVAs were conducted using GraphPad Prism to test for
treatment differences. When treatment differences were found, post-hoc
comparisons by Dunnett’s or Bonferroni’s tests were conducted after the ANOVAs to
determine significant differences among treatment groups.

For all studies, p < 0.05 was accepted as statistically significant.

RESULTS
54Mn

uptake into bBMECs was initially studied up to 120 minutes to assess linearity

during that time (Figure 1 Inset). Regression analysis showed Mn uptake results
obtained at pH 7.4 and 6.4 were better fit by linear than non-linear regression. The
95% confidence intervals for the slopes excluded one another. Mn2+ uptake at pH
6.4 was significantly less than at 7.4. For the remaining studies, 30-minute uptake
was used as representative.

At the 120 minute time point, the intracellular Mn concentration (overall means of
10.6 and 3.4 µM for pH 7.4 and 6.4, respectively), exceeded the media Mn
concentration (184 nM) by at least 10 fold. In later experiments using 54Mn at a lower
specific activity and higher total Mn (477 vs. 184 nM), the intracellular concentration
at 30 minutes was at least 3-fold, and usually 10-fold, greater than the extracellular
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concentration. Intracellular Mn concentration was higher than extracellular Mn
concentration in all experiments under control conditions.

Mn uptake was inversely related to proton concentration. This was noted in the time
course of Mn uptake conducted at pH 6.4 and 7.4 as well as the uptake study
conducted at pH 5.4, 6.4, 6.9, 7.4 and 7.9 (Figure 1). The results from cells treated
at pH 5.4 for 30 minutes are not shown because they produced only 6% of the
formazan product/mg protein that was found in control (pH 7.4) cells, indicating
severe cell toxicity.

Temperature-dependence of uptake
Mn uptake into bBMECs was measured at five temperatures. The data were
graphed as an Arrhenius plot of natural log of the uptake rate versus inverse of
absolute temperature (Figure 2). The plot appears to have a change in slope (a
breakpoint); however, the data are not significantly non-linear. Rearrangement of the
Arrhenius equation, as follows, generated the activation energy (Ea).

Ea = -R * (d ln k)/d (1/T)

where R is the ideal gas constant, k is the uptake rate and d(ln k)/d(1/T) is the slope
of Figure 2. Ea was determined to be 27 kJ/mol.
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Sodium- and energy-independence of uptake
Mn uptake into bBMECs was not inhibited by replacement of the sodium in the
uptake medium (Table 1). Sodium replacement by choline resulted in a significant
increase of Mn uptake into bBMECs. Energy production inhibitors reduced MTT
conversion to formazan by ~ 40% (results not shown) but did not significantly affect
Mn uptake into bBMECs (Table 1).

Calcium-dependence of bBMEC uptake and brain influx
There was an inverse relationship between Ca concentration and brain Mn influx
(Figure 3) as well as Mn uptake and Ca concentration in bBMECs (Table 2).
However, Mn did not inhibit brain Ca influx (Figure 3).

La3+ increased brain Mn influx (Figure 4), and Ni did not decrease Mn influx into rat
brain (Figure 5). Verapamil did not significantly inhibit Mn influx compared to control.
Mean Mn influx values ± SEM (n=5-6) for control versus verapamil were 20.6 ± 2.7
vs. 14.9 ± 1.6; 12.4 ± 2.5 vs. 6.6 ± 0.4; and 1218 ± 108 vs. 863 ± 62 x 10-5 ml/s/g for
parietal cortex, caudate or choroid plexus, respectively. Another voltage-gated Ca
channel inhibitor, amiloride, did not inhibit brain Mn influx (Ca was not tested). Mn
influx values for control versus amiloride-treated brains were 6.2 ± 2.2 vs. 11.3 ± 5.7;
6.7 ± 0.7 vs. 4.7 ± 1.6; 2197 ± 421 vs. 1756 ± 178 x 10-5 ml/s/g for the parietal
cortex, caudate or choroid plexus, respectively (mean ± SEM of 4 control and 3
treated brains).
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Brain Ca influx was measured concurrently with Mn influx for control perfusates and
those with La, Ni or verapamil. Control Ca influx values (mean ± SEM, n=5-6) were
85.1 ± 15.7, 61.4 ± 11 and 873 ± 177 x 10-5 ml/s/g for parietal cortex, caudate and
choroid plexus, respectively. Ca influxes with La were 75 ± 22.9, 55.1 ± 27.2 and
672 ± 145 x 10-5 ml/s/g. Ca influx with Ni were 62.1 ± 18.5; 39.6 ± 10; and 1058 ±
497 x 10-5 ml/s/g for parietal cortex, caudate and choroid plexus, respectively; with
verapamil, 80.4 ± 10.5; 54.7 ± 7.5; and 922 ± 182 x 10-5 ml/s/g. Brain Ca influx was
not significantly affected by any of these treatments within this short time course.

La3+ decreased Ca uptake into bBMECs without having a significant effect on Mn
uptake (Table 2). Ni significantly inhibited Ca and Mn uptake into bBMECs (Table
2). In addition to its effect on brain influx, verapamil also produced parallel, nonsignificant decreases of Mn and Ca uptake into bBMECs (Table 2).

Vanadate (1 mM) did not significantly inhibit Mn influx into the tested brain regions or
the choroid plexus following its co-perfusion with 54Mn2+ for 90 seconds. Mean
values ± SEM (4 rats per group) were 49.2 ± 21.1 vs. 51.2 ± 23.8, 7.4 ± 2.8 vs. 17.0
± 10.5 and 759 ± 347 vs. 450 ± 190 x 10-5 ml/s/g for control vs. vanadate-treated
parietal cortex, caudate and choroid plexus tissues. When the brain was perfused
with 1 mM vanadate for 90 s and then immediately switched to a co-perfusion of
vanadate with 54Mn2+, Mn influx was not inhibited by the vanadate pre-wash
exposure. The control and vanadate-treated brain Mn influx values were 4.4 ± 0.9
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vs. 16.4 ± 7.7, 2.6 ± 0.7 vs. 4.0 ± 0.7 and 247 ± 35 vs. 746 ± 53 x 10-5 ml/s/g for the
parietal cortex, caudate and choroid plexus regions of the brain, respectively (mean
± SEM for 6 rats per group). A higher concentration of vanadate (10 mM) also failed
to inhibit brain Mn influx. The parietal cortex, caudate and choroid plexus Mn influx
values were 13.4 ± 4.4 vs. 21.5 ± 6.6, 7.4 ± 1.6 vs. 11.4 ± 4.1 and 1063 ± 294 vs.
1376 ± 318 x 10-5 ml/s/g brain for control vs. vanadate-treated brain, respectively
(mean ± SEM for 5 rats per group). Vanadate did not change the distribution of Mn
in the endothelial cells or the brain parenchyma. Endothelial cells retained 10 and
13% of the total Mn entering brain following perfusion with Mn or Mn with vanadate
(10 mM; data not shown). Therefore, brain parenchyma contained 90 and 87% of
the Mn that had crossed the BBB.

Contrary to in situ perfusion results, addition of 3 µM or 1 mM vanadate inhibited Mn
uptake into bBMECs (Table 2). Furthermore, this effect persisted after vanadate was
washed out. Cells treated 30 minutes with 1 mM vanadate, washed twice and
incubated with vanadate-free uptake media had only 39% of control Mn uptake
(Table 2).

Addition of p-hydroxyhippuric acid (0.4 mM) to the brain perfusate did not inhibit
brain Mn influx (Ca influx was not tested). The control and experimental brain Mn
influx values were 7.4 ± 0.6 vs. 12.7 ± 1.8, 8.6 ± 1.4 vs. 6.7 ± 0.6 and 1375 ± 100 vs.
1310 ± 122 x 10-5 ml/s/g for the parietal cortex, caudate and choroid plexus,
respectively (mean ± SEM for 6 control and 7 treated rats). In the cerebellum only,
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there was a non-significant trend for a p-hydroxyhippuric acid-induced decrease of
Mn influx (11.0 ± 1.9 vs. 5.7 ± 0.6 x 10-5 ml/s/g for control vs. p-hydroxyhippurate).
Studies with modulators of store-operated Ca channels
CPA significantly increased Mn and Ca uptake when studied concurrently (Table 2).
Ca uptake following thapsigargin treatment was not significantly greater than control
(P=0.07), although Ca uptake in thapsigargin-treated cells was 1.4-10 fold greater
than in control cells in each experimental replicate. Mn uptake was significantly
greater in thapsigargin-treated than in control cells (Table 2).

DISCUSSION
This research examined the mechanism of carrier-mediated Mn entry into the rat
brain across the BBB. The first objective was to determine general characteristics of
carrier-mediated Mn uptake. The second objective tested the hypothesis that brain
Mn entry was mediated by one or more Ca transporters. The results suggest that
brain Mn influx occurs through at least one pathway which is not Ca-mediated as
well as one or more pathways involving SOCs.

Our results are consistent with previous reports of carrier-mediated Mn uptake at the
BBB (Aschner and Aschner, 1990; Murphy, et al., 1991; Rabin, et al., 1993; Aschner
and Gannon, 1994; Crossgrove, et al., 2003). Here, we report concentrative Mn
uptake, providing evidence of a carrier-mediated process. The temperaturedependence study suggests that the activation energy of this process is 27 kJ/mol,
consistent with values reported for ion channels (18-34 kJ/mol) by
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electrophysiological techniques (Liu et al, 1996). This supports the suggestion that
brain Mn uptake occurs through one or more carrier-mediated processes. Finally,
the negative correlation between proton concentration and Mn uptake into bBMECs
agrees with our report that Mn uptake is not likely to occur through the divalent metal
transporter-1, which co-transports a proton with a divalent metal ion (Crossgrove
and Yokel, 2004).

Brain Mn uptake was not inhibited by 2,4-dinitrophenol, azide or 2-deoxyglucose,
suggesting it is not directly dependent on an energy source mediated by ATP
hydrolysis. Nor was brain Mn uptake inhibited by ouabain, showing it to be
independent of Na+/K+-ATPase. While these studies did not provide evidence for
energy dependence, the concentrative uptake seen in the bBMEC studies must rely
on an energy source or electron transfer. The conversion of MTT to formazan in
treated cells was ~60% of control cells, suggesting reduction, but not elimination, of
cell redox potential when ATP-inhibitors were present. Therefore, the lack of effect
by metabolic inhibitors may be due either to the lack of an ATP-dependent Mn
transporter or to the ability of the ATP-dependent Mn transporter(s) to continue at
their normal rate when ATP is reduced to 60%. Alternatively, the pH dependence
suggests that there might be an electromotive driving force maintaining Mn uptake.
However, the positive correlation between Mn uptake and pH suggest that it is not
an inward proton or cation electromotive force. This suggests that the Mn transporter
may be a proton or cation antiporter.
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Brain Mn uptake was sodium-independent, suggesting the uptake carrier(s) do not
utilize a sodium gradient as a driving force. Replacing sodium with choline increased
brain Mn uptake. One report provides evidence that Mn inhibits choline uptake at the
BBB (Lockman et al., 2001). The authors suggested that the choline transporter may
be involved in brain Mn uptake, though they did not test the effect of choline on Mn
uptake. Choline uptake into rat brain, like Mn uptake, has been described to be
sodium-independent (Allen and Smith, 2001). Mn and choline may share one or
more transport process(es). On the other hand, choline increased Mn uptake, which
would not be expected if they were competing for an uptake process. While the
basis of any interaction between Mn and choline is unclear, it is clear that Mn uptake
at the BBB is sodium independent.

Ca appears to play a significant role in Mn influx at the BBB. When Ca was not
added to the perfusate, Mn influx was significantly greater than in the presence of
normal (1.5 mM) Ca. Brain Mn influx was slightly, but not significantly, less in the
presence of 9 mM Ca. Ca has been shown to inhibit Mn uptake into astrocytes in
competitive and non-competitive manners (Aschner et al., 1992). Mn uptake into
bBMECs also increased in the absence of added Ca compared to uptake media with
normal (1.5 mM) Ca. Overall, Ca concentration correlates negatively with Mn influx.
This concentration-dependent effect does not distinguish whether Ca and Mn
directly compete for the same carrier or whether Ca indirectly modulates Mn uptake.
On the other hand, added Mn did not inhibit 45Ca influx into rat brain compared to
control (no added Mn) perfusate (Figure 3), suggesting Mn and Ca do not compete
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for the same carrier, or that the capacity of any common carrier(s) is very large.
Depending on the affinity of the Ca carrier for Mn, the 10-fold greater concentration
of Mn above that of Ca used in the present studies may not be sufficient to inhibit
brain Ca influx. A 6-fold increase in Ca failed to significantly inhibit Mn influx, which
suggests either that they have separate carriers or that their shared pathway(s) has
a great substrate capacity.

Mn uptake into bBMECs was inhibited by Ni, consistent with a role for Ca channels
in Mn uptake. Ni has been shown to inhibit receptor-operated Ca channels and
store-operated channels (Cui and Dannies, 1992; Kukkonen et al., 2001). Ni is
thought to be a rather specific inhibitor of Ca channels, as it did not appear to be a
substrate for the channels it blocks (Shibuya and Douglas, 1992; Jones and Sharpe,
1994). In the current study, Ni blocked Mn uptake (to 12% control) in bBMECs in a
manner parallel to its effect on Ca uptake (15% control), providing strong evidence
that Mn uptake may occur through Ca uptake pathways. An alternative explanation
is that Ni blocks equally two or more separate pathways for Mn and Ca uptake,
rather than our suggestion of a common pathway. In perfusion studies, Ni failed to
block Mn and Ca brain influx. The difference between the animal and bBMEC
studies may be due to the shorter experimental duration of in situ brain perfusion (90
s) than bBMEC studies (30 min). The lack of brain Mn influx inhibition by Ni may be
due to Ni’s inability to block Ca influx. The animal data, therefore, do not reveal any
information whether Mn and Ca share the same BBB carrier(s) that are inhibited by
Ni.
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Ni significantly inhibited choroid plexus Mn influx; however, it did not inhibit Ca influx
into the choroid plexus. This suggests that Mn and Ca may have separate uptake
mechanisms at this blood-cerebrospinal fluid interface. The choroid plexus is
believed to be the main site of Ca influx into brain. If the choroid plexus is vital in
maintaining Ca homeostasis as implicated (Murphy et al., 1989; Keep et al., 1999),
then perhaps the carriers expressed at the choroid plexus have a stronger affinity for
Ca, rendering the Ni treatment an ineffective inhibitor of Ca influx. Alternatively, Ni
may not have had sufficient time to inhibit Ca transporters, or the inhibition of Mn
uptake into choroid plexus is independent of Ca transporters.

The results with the Ca transporter blocker, La3+, suggest that a non-Ca pathway
also mediates brain Mn influx. La3+ inhibition of Ca uptake has been shown in
voltage-gated Ca channels, receptor-operated Ca channels and store-operated Ca
channels (Cui and Dannies, 1992; Davidson and Guo, 2000; Liu and Ambudkar,
2001; Wu et al., 2001). In perfusion studies, La3+ significantly increased Mn influx
more than 4-fold. A literature search did not reveal any other reports of La3+
increasing transporter or carrier activity. There was no effect on brain Ca influx in the
present studies, suggesting La3+ did not block Ca influx. Furthermore, the results
suggest that the La3+ effect on Mn influx at the BBB is independent of Ca. In bBMEC
studies, La3+ did not significantly affect Mn or Ca uptake. While rat studies indicated
that La3+ increases Mn, but not brain Ca influx, bBMEC studies suggested a nonsignificant decrease in Mn and Ca uptake. The results suggest that Mn uptake at the
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BBB also occurs through one or more Ca-independent processes, since La3+
increases Mn uptake without affecting Ca.

Another explanation for the unexpected increase in Mn uptake by La3+ is transstimulation of the endothelial cells. This process occurs when a substrate on one
side of the cell membrane increases substrate transfer from the other side. transStimulation has been shown to play a role in the uptake of glucose into bovine
mammary epithelial cells (Xiao and Cant, 2003), agmatine through the human
extraneuronal monoamine transporter (Grundemann et al., 2003) and sorbitol into a
renal medullary cell line (Schuttert et al., 2002). 54Mn efflux from astrocytes was
trans-stimulated by 55Mn in the media (Aschner, et al., 1992). La3+ may enter cells
rapidly and then cause greater Mn influx through trans-stimulation.

In bBMEC studies, Mn entry was inhibited by vanadate (0.003 and 1 mM). Despite
indications in bBMECs, addition of 1 or 10 mM vanadate to 54Mn in the in situ brain
perfusate did not decrease brain Mn influx. Ca-ATPases are found on both the
luminal and abluminal surface of brain endothelial cells, which may confound our
interpretation of the results (Manoonkitiwongsa et al., 2000). Mn distribution into
endothelial and brain cell plus extracellular fluid fractions, as measured with the
capillary depletion method, was unaltered by vanadate, suggesting neither brain Mn
influx nor efflux are mediated by Ca-ATPase. Although vanadate inhibited Mn uptake
into bBMECs, it did not inhibit Mn influx across the BBB. p-Hydroxyhippuric acid, a
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relatively selective Ca-ATPase inhibitor, also did not inhibit brain Mn influx, providing
further evidence against a role for Ca-ATPase.

Studies with inhibitors of voltage-gated Ca channels also failed to implicate these
channels in brain Mn uptake. This is not surprising, as endothelial cells are not
considered excitable and would not be expected to use voltage-gated channels. On
the other hand, it was recently determined that brain endothelial cells do express Ltype Ca channels (Bossu et al., 1992). Verapamil did not significantly decrease Mn
or Ca influx. In a similar study in the absence of 45Ca, verapamil and amiloride failed
to alter brain 54Mn influx. These results suggest brain Mn entry is not likely to occur
through voltage-gated Ca channels under physiological conditions.

Thapsigargin and CPA significantly increased Mn uptake, 2.5- and 2.6-fold,
respectively, consistent with the hypothesis that SOCs play a role. Thapsigargin did
not significantly increase Ca uptake (P=0.07) despite the 1.4-10-fold increase in Ca
uptake. Earlier reports implicated SOCs in the influx of metals across the BBB. Lead
uptake into bBMECs was increased by 1.7- and 2.1-fold following treatment with
CPA or thapsigargin, respectively (Kerper and Hinkle, 1997b). The pH dependence
of Mn uptake is also consistent with a role for SOCs in Mn influx at the BBB. Storeoperated Ca influx was inhibited by low extracellular pH in human microglia (Khoo et
al., 2001). These results suggest that brain Mn uptake occurs through the SOCs.
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In summary, there are at least two transporters for brain Mn influx. Mn entry into
brain occurs through at least one pathway that does not have a high affinity for Ca,
as evidenced with the La3+ data. Mn influx also is likely to occur through a Niblocked, CPA-induced Ca pathway, which is consistent with store-operated Ca
channels.

BBB Mn influx through SOCs 25
REFERENCES
Allen DD, Smith QR. Characterization of the blood-brain barrier choline transporter
using the in situ rat brain perfusion technique. J Neurochem 2001; 76(4):
1032-1041
Aschner M, Aschner JL. Manganese transport across the blood-brain barrier:
relationship to iron homeostasis. Brain Res Bull 1990; 24(6): 857-860
Aschner M, Gannon M. Manganese (Mn) transport across the rat blood-brain barrier:
saturable and transferrin-dependent transport mechanisms. Brain Res Bull
1994; 33(3): 345-349
Aschner M, Gannon M, Kimelberg HK. Manganese uptake and efflux in cultured rat
astrocytes. J Neurochem 1992; 58(2): 730-735
Audus KL, Ng L, Wang W, Borchardt RT. Brain microvessel endothelial cell culture
systems. In: Models for Assessing Drug Absorption and Metabolism, Ronald
T. Borchardt Ea, Eds., ed., New York, Plenum Press, 1996, 239-258
Baldi C, Vazquez G, Boland R. Characterization of a 1,25(OH)2-vitamin D3responsive capacitative Ca2+ entry pathway in rat osteoblast-like cells. J Cell
Biochem 2002; 86(4): 678-687
Bossu JL, Elhamdani A, Feltz A, Tanzi F, Aunis D, Thierse D. Voltage-gated Ca
entry in isolated bovine capillary endothelial cells: evidence of a new type of
BAY K 8644-sensitive channel. Pflugers Arch 1992; 420(2): 200-207
Bowman PD, Ennis SR, Rarey KE, Betz AL, Goldstein GW. Brain microvessel
endothelial cells in tissue culture: a model for study of blood-brain barrier
permeability. Ann Neurol 1983; 14(4): 396-402

BBB Mn influx through SOCs 26
Chandra SV, Shukla GS, Srivastava RS, Singh H, Gupta VP. An exploratory study of
manganese exposure to welders. Clin Toxicol 1981; 18(4): 407-416
Conrad ME, Umbreit JN, Moore EG, Hainsworth LN, Porubcin M, Simovich MJ,
Nakada MT, Dolan K, Garrick MD. Separate pathways for cellular uptake of
ferric and ferrous iron. Am J Physiol Gastrointest Liver Physiol 2000; 279(4):
G767-774
Couper J. On the effects of black oxide of manganese when inhaled into the lungs.
Brit Ann Med Pharm,Vital Stat Gen Sci 1837; 1: 41-42
Crossgrove J, Yokel R. Manganese distribution across the blood-brain barrier III;
The divalent metal transporter-1 is not the major mechanism mediating brain
manganese uptake. NeuroToxicol 2004; 25(3): 451-460
Crossgrove JS, Allen DD, Bukaveckas BL, Rhineheimer SS, Yokel RA. Manganese
distribution across the blood-brain barrier I. Evidence for carrier-mediated
influx of manganese citrate as well as manganese and manganese
transferrin. NeuroToxicol 2003; 24(1): 3-13
Cui ZJ, Dannies PS. Thyrotropin-releasing hormone-mediated Mn2+ entry in
perifused rat anterior pituitary cells. Biochem J 1992; 283 ( Pt 2): 507-513
Davidson RM, Guo L. Calcium channel current in rat dental pulp cells. J Membr Biol
2000; 178(1): 21-3
Dobrydneva Y, Blackmore P. 2-Aminoethoxydiphenyl borate directly inhibits storeoperated calcium entry channels in human platelets. Mol Pharmacol 2001;
60(3): 541-552

BBB Mn influx through SOCs 27
Edlund GL, Halestrap AP. The kinetics of transport of lactate and pyruvate into rat
hepatocytes. Evidence for the presence of a specific carrier similar to that in
erythrocytes. Biochem J 1988; 249(1): 117-126
Fasolato C, Hoth M, Penner R. Multiple mechanisms of manganese-induced
quenching of fura-2 fluorescence in rat mast cells. Pflugers Arch 1993; 423(34): 225-231
Finley JW. Manganese uptake and release by cultured human hepato-carcinoma
(Hep-G2) cells. Biol Trace Elem Res 1998; 64(1-3): 101-118
Goddard WP, Coupland K, Smith JA, Long RG. Iron uptake by isolated human
enterocyte suspensions in vitro is dependent on body iron stores and inhibited
by other metal cations. J Nutr 1997; 127(1): 177-183
Grundemann D, Hahne C, Berkels R, Schomig E. Agmatine is efficiently transported
by non-neuronal monoamine transporters extraneuronal monoamine
transporter (EMT) and organic cation transporter 2 (OCT2). J Pharmacol Exp
Ther 2003; 304(2): 810-817
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF,
Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a
mammalian proton-coupled metal-ion transporter. Nature 1997; 388(6641):
482-488
Huang CC, Chu NS, Lu CS, Wang JD, Tsai JL, Tzeng JL, Wolters EC, Calne DB.
Chronic manganese intoxication. Arch Neurol 1989; 46(10): 1104-1106

BBB Mn influx through SOCs 28
Hudnell HK. Effects from environmental Mn exposures: a review of the evidence
from non-occupational exposure studies. NeuroToxicol 1999; 20(2-3): 379397
Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical
exposure level, and sensitive tests. NeuroToxicol 1999; 20(2-3): 315-323
Jones KT, Sharpe GR. Ni2+ blocks the Ca2+ influx in human keratinocytes following
a rise in extracellular Ca2+. Exp Cell Res 1994; 212(2): 409-413
Keen CL, Ensunsa JL, Clegg MS. Manganese metabolism in animals and humans
including the toxicity of manganese. In: Manganese and its role in biological
processes, Sigel A and Sigel H, ed., New York, Marcel Dekker, Inc., 2000,
89-121
Keen CL, Lönnerdal B. Toxicity of essential and beneficial metal ions. Manganese.
In: Handbook of Metal-Ligand Interactions in Biological Fluids, Berthon G, ed.,
New York, NY, Marcel Dekker, Inc., 1995, 683-688
Keep RF, Ulanski LJ, 2nd, Xiang J, Ennis SR, Lorris Betz A. Blood-brain barrier
mechanisms involved in brain calcium and potassium homeostasis. Brain Res
1999; 815(2): 200-205
Kerper LE, Hinkle PM. Cellular uptake of lead is activated by depletion of
intracellular calcium stores. J Biol Chem 1997a; 272(13): 8346-8352
Kerper LE, Hinkle PM. Lead uptake in brain capillary endothelial cells: activation by
calcium store depletion. Toxicol Appl Pharmacol 1997b; 146(1): 127-133

BBB Mn influx through SOCs 29
Khoo C, Helm J, Choi HB, Kim SU, McLarnon JG. Inhibition of store-operated
Ca(2+) influx by acidic extracellular pH in cultured human microglia. Glia
2001; 36(1): 22-30
Kim YV, Di Cello F, Hillaire CS, Kim KS. Differential Ca2+ signaling by thrombin and
protease-activated receptor-1-activating peptide in human brain
microvascular endothelial cells. Am J Physiol Cell Physiol 2004; 286(1):C3142
Klaassen CD. Biliary excretion of manganese in rats, rabbits, and dogs. Toxicol Appl
Pharmacol 1974; 29(3): 458-468
Kondakis XG, Makris N, Leotsinidis M, Prinou M, Papapetropoulos T. Possible
health effects of high manganese concentration in drinking water. Arch
Environ Health 1989; 44(3): 175-178
Kukkonen JP, Lund PE, Akerman KE. 2-aminoethoxydiphenyl borate reveals
heterogeneity in receptor-activated Ca(2+) discharge and store-operated
Ca(2+) influx. Cell Calcium 2001; 30(2): 117-129
Lee J-W. Manganese Intoxication. Arch Neurol 2000; 57(4): 597-599
Liu X, Ambudkar IS. Characteristics of a store-operated calcium-permeable channel:
sarcoendoplasmic reticulum calcium pump function controls channel gating. J
Biol Chem 2001; 276(32): 29891-29898
Lockman PR, Roder KE, Allen DD. Inhibition of the rat blood-brain barrier choline
transporter by manganese chloride. J Neurochem 2001; 79(3): 588-594
Manoonkitiwongsa PS, Whitter EF, Wareesangtip W, McMillan PJ, Nava PB, Schultz
RL. Calcium-dependent ATPase unlike ecto-ATPase is located primarily on

BBB Mn influx through SOCs 30
the luminal surface of brain endothelial cells. Histochem J 2000; 32(5): 31324
Mason MJ, Mayer B, Hymel LJ. Inhibition of Ca2+ transport pathways in thymic
lymphocytes by econazole, miconazole, and SKF 96365. Am J Physiol 1993;
264(3 Pt 1): C654-662
Murphy VA, Smith QR, Rapoport SI. Uptake and concentrations of calcium in rat
choroid plexus during chronic hypo- and hypercalcemia. Brain Res 1989;
484(1-2): 65-70
Murphy VA, Wadhwani KC, Smith QR, Rapoport SI. Saturable transport of
manganese(II) across the rat blood-brain barrier. J Neurochem 1991; 57(3):
948-954
Ono K, Komai K, Yamada M. Myoclonic involuntary movement associated with
chronic manganese poisoning. J Neurol Sci 2002; 199(1-2): 93-96
Poole RC, Halestrap AP, Price SJ, Levi AJ. The kinetics of transport of lactate and
pyruvate into isolated cardiac myocytes from guinea pig. Kinetic evidence for
the presence of a carrier distinct from that in erythrocytes and hepatocytes.
Biochem J 1989; 264(2): 409-418
Rabin O, Hegedus L, Bourre JM, Smith QR. Rapid brain uptake of manganese (II)
across the blood-brain barrier. J Neurochem 1993; 61: 509-517
Schuttert JB, Fiedler GM, Grupp C, Blaschke S, Grunewald RW. Sorbitol transport in
rat renal inner medullary interstitial cells. Kidney Int 2002; 61(4): 1407-1415
Shibuya I, Douglas WW. Calcium channels in rat melanotrophs are permeable to
manganese, cobalt, cadmium, and lanthanum, but not to nickel: evidence

BBB Mn influx through SOCs 31
provided by fluorescence changes in fura-2-loaded cells. Endocrinol 1992;
131(4): 1936-1941
Wedler FC, Denman RB. Glutamine synthetase: the major Mn(II) enzyme in
mammalian brain. Curr Top Cell Reg 1984; 24: 153-169
Wu S, Sangerman J, Li M, Brough GH, Goodman SR, Stevens T. Essential control
of an endothelial cell ISOC by the spectrin membrane skeleton. J Cell Biol
2001; 154(6): 1225-1233
Xiao C, Cant JP. The glucose transporter in bovine mammary epithelial cells is an
asymmetric carrier that exhibits cooperativity and trans-stimulation. Am J
Physiol Cell Physiol 2003; 285(5): C1226-1234
Yamakami J, Sakurai E, Sakurada T, Maeda K, Hikichi N. Stereoselective bloodbrain barrier transport of histidine in rats. Brain Res 1998; 812(1-2): 105-112
Yokel R, Wilson M, Harris W, Halestrap A. Aluminum citrate uptake by immortalized
brain endothelial cells: Implications for its blood-brain barrier transport. Brain
Res 2002; 930(1-2): 101-110
Yokel RA, Crossgrove JS, Bukaveckas BL. Manganese distribution across the
blood-brain barrier II. Manganese efflux from the brain does not appear to be
carrier mediated. NeuroToxicol 2003; 24(1): 15-22

BBB Mn influx through SOCs 32
Table 1. Characteristics of 54Mn2+ uptake into bBMECs
Mn uptake
Treatment
(% control ± SEM)
Control (122 mM Na+)
100 ± 7
61 mM Na+, 61 mM choline
97 ± 18
+
122 mM% Choline (no Na )
160 ± 6*
122 mM Li+ (no Na+)
90 ± 9
Control (vehicle)
Ouabain
Control (vehicle)
2,4-Dinitrophenol
Azide
2-Deoxyglucose
* = significantly different from control.

n
6
3
5
4

100 ± 10
129 ± 15

3
3

100 ± 6
102 ± 5
124 ± 4
84 ± 8

8
6
3
4
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Table 2. Mn and Ca uptake into bBMECs in the presence of Ca transporter
inhibitors
Ca uptake
Mn uptake
Treatment
(% control ± SEM) (% control ± SEM) N
Control
100 ± 18
5
2+
No Ca
170 ± 29*
4
Control
Vanadate (0.003 µM)
Vanadate (1 mM)
Vanadate pretreatment (1 mM)

100 ± 5
64 ± 3*
53 ± 4*
39 ± 4*

4
3
3
3

Control
La3+
Ni2+
Verapamil

100 ± 17
58 ± 25*
15 ± 15*
54 ± 3

100 ± 8
64 ± 24
12 ± 3*
81 ± 2

4
4
3
3

Control (vehicle)
100 ± 30
CPA
418 ± 98*
Thapsigargin
415 ± 212
* =significantly different from control.

100 ± 13
265 ± 48*
252 ± 23*

3
4
4
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Figure 1. Mn uptake into bBMECs correlates inversely with proton concentration.
Values are mean percent of control (pH 7.4) uptake ± SEM for 3-6 experiments,
following 30 minute incubation. Inset: Time dependent uptake of Mn at pH 6.4
versus 7.4 is shown. * denotes a significant difference from control

Figure 2. The Arrhenius plot shows temperature-dependent Mn uptake into
bBMECs. Values shown are the natural log of the mean ± SEM of uptake (pmol/30
min/mg).

Figure 3. Mn influx correlates negatively with Ca concentration following in situ
perfusion, but Mn concentration has no effect on Ca influx. A) Mn and B) Ca influx
values into brain are shown (mean ± SEM of 4-5 animals).

Figure 4. La increased Mn influx into rat brain. Values shown are mean ± SEM
(n=5). The Y-axis in panel A is different from previous Mn influx graphs.

Figure 5. Ni did not decrease Mn (A) influx into rat brain across the BBB. Values
shown are mean ± SEM (n=5). * significantly different from control
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